Loading
A phase 2 trial of Zelenectide pevedotin in advanced solid tumours, run by BicycleTx Limited, active and no longer recruiting.
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer is a phase 2 interventional study registered as NCT06840483 by BicycleTx Limited, with 66 participants enrolled, started 2025-03-03 and due to reach its primary completion in 2028-06-30. Interventions recorded: Zelenectide pevedotin (BT8009).
Shares Zelenectide pevedotin, Bicycle Therapeutics, Peptide-drug & small-molecule-drug conjugates and the tag pipeline.
Shares Zelenectide pevedotin, Bicycle Therapeutics, Peptide-drug & small-molecule-drug conjugates and the tag pipeline.
Shares Bicycle Therapeutics, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Bicycle Therapeutics and the tag pipeline.
Shares Zelenectide pevedotin, Bicycle Therapeutics, Peptide-drug & small-molecule-drug conjugates.
Shares Peptide-drug & small-molecule-drug conjugates and the tag pipeline.
Shares Peptide-drug & small-molecule-drug conjugates and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.